![]() |
5th International AIDS Society Conference on HIV Pathogenesis and TreatmentCape Town - July 19 - 22, 2009 |
OPTIMIZATION OF ABBOTT M2000 REALTIME HIV-1 VIRAL LOAD ASSAY ON BREASTMILK, DRIED BLOOD SPOTS, SEMINAL PLASMA, AND CEREBROSPINAL FLUID
IAS Conf HIV Pathog Treat 2009 Jul 19-22;5th: Abstract No. MOPDB103
A. Loftis1, R. Kshatriya1, K. McCall-Culbreath2, S. Fiscus
1, J. Nelson1
1University of North Carolina at Chapel Hill, Microbiology and Immunology, Chapel Hill, United States, 2University of North Carolina at Chapel Hill, Medicine, Chapel Hill, United States
BACKGROUND: The latest technology for measuring HIV-1 RNA in plasma is the real-time PCR platform. Abbott's m2000 RealTime HIV-1 assay is CE-marked and FDA-approved for plasma only, but has not been optimized for off-label use with other sample types. Measurement of HIV-1 RNA levels in other body fluids, including breastmilk (BMK), dried blood spots (DBS), seminal plasma, and cerebrospinal fluid (CSF), is important for understanding pathogenesis and transmission of HIV. More accurate and precise methods for measuring HIV RNA levels in these other sample types are needed.
METHODS: Plasma, BMK, whole blood, semen, and CSF were obtained from uninfected donors. 1:10 dilutions of an HIV-1 virus stock was added to plasma, whole BMK, whole blood (for DBS), seminal plasma, and CSF to generate series of samples containing 0-6 log10 copies of HIV-1 per ml of fluid. Each sample type was lysed in different volumes of lysis buffer, with BMK and semen treated with proteinase K prior to extraction. Different m2000sp protocols were used to accommodate different sample volumes after addition of lysis buffer. HIV-1 RNA levels were measured off-label using the RealTime HIV-1 viral load assay in the m2000rt after extraction and the data from the different sample types were compared with the results from the spiked plasma samples.
RESULTS: The results from the dilution series in plasma, BMK, semen, CSF, and DBS had linear results compared to the nominal cp/ml. Comparison of the samples to plasma indicated that HIV-1 RNA recovery after adjusting for sample input and dilution was near 100% from semen, CSF, and DBS, and approximately 50% from BMK.
CONCLUSIONS: The Abbott m2000 RealTime HIV-1 assay works well for measuring HIV-1 RNA levels in BMK, semen, CSF, and DBS. More accurate and precise measurements are critical for understanding pathogenesis and transmission, and for clinical trial evaluations.
Download PDF of this abstract.
Download Power Point Presentation.
2009-07-22
MOPDB103
Poster Discussion MOPDB1 - Update on Diagnosing and Monitoring
Copyright © 2009 - International AIDS Society (IAS). All information and content relating to the abstracts from the 5th International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you. Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.